Sabrina Dunbar | executive |
Katherine Stueland | executive |
Kevin Feeley | executive |
Daniel Brennan | analyst |
Mark Massaro | analyst |
Matthew Sykes | analyst |
Matthew Stanton | analyst |
Ladies and gentlemen, thank you for standing by, and welcome to the GeneDx First Quarter 2024 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. It is now my pleasure to introduce Commercial Chief of Staff, Sabrina Dunbar.
Thank you, operator, and thank you to everyone for joining us today.
On the call, we have Katherine Stueland, President and Chief Executive Officer; and Kevin Feeley, Chief Financial Officer.